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ABSTRACT The effect of in ovo administration of
chicken growth hormone (cGH) on growth rate and
efficiency of gain, organ, and long bone growth of
42-d-old broiler chickens was investigated. Eggs were
injected once with 100 mL vehicle (0.03 M NaHCO3, 0.15
M NaCl, pH 8.3) per embryo or vehicle containing 100
ng cGH/100 mL per embryo (n = 630 eggs total) on one
of the following Days: 1, 4, or 7 through 18 of
embryogenesis. There was no significant difference in
hatchability between control and cGH treatment groups
on any given injection day. Cumulative feed conversion
of all treatment groups was improved relative to their
respective control groups (P < 0.05). In ovo administra-
tion of cGH on Day 15 or 16 of incubation increased
body weights (P < 0.01) of female broilers. On the other
hand, body weights of male broilers were significantly
increased by treatment on Day 1 (P < 0.04). Breast
weights of female broilers from treatment groups Day 15
or 16 were increased (P < 0.01, P < 0.05, respectively).
Liver weights of female broilers from treatment groups
Day 1 and 15 were increased (P < 0.05, P < 0.01,
respectively). In contrast, in ovo administration of cGH
on Day 11 of incubation increased liver weights of male
broilers (P < 0.03). There was no significant difference
between control and treatment groups, in terms of heart
or leg weights, or in Warner-Bratzler shear force of
Pectoralis profundus muscle. Hydroxyproline concentra-
tion and cross-sectional area of female broiler tibias from
treatment groups Day 11 or Day 16 were increased (P <
0.05), and ultimate breaking strength (stress) of tibias
from the same groups was reduced (P < 0.05). In ovo
administration of cGH altered growth and tissue
development of broiler chickens in a time by sex
dependent fashion.
(Key words: in ovo, growth hormone, feed efficiency, muscle, bone)
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INTRODUCTION
Growth hormone (GH) is required for normal de-
velopment of chickens. Serum growth hormone is first
detectable on Day 12 of embryonic development but
remains under 10 ng/mL until Day 20 of incubation
(Kikuchi et al., 1991). Growth hormone receptors and
signal transduction mechanisms are developed during
the latter embryonic stages, starting on about Day 12
(Kuhn et al., 1986; Berghman et al., 1989; Porter et al.,
1995). The circulating concentration of GH has been
positively correlated with growth rate in early posthatch
chickens (Burke and Marks, 1982). Moreover, plasma
GH decreases as growth rate declines with posthatch
age (Vasilatos-Younken and Zarkower, 1987; Vasilatos-
Younken et al., 1990). On the other hand, slower
growing chickens display higher circulating concentra-
tions of GH than faster growing chickens (Burke and
Marks, 1982; Stewart and Washburn, 1983; Goddard et
al., 1988).
When growth in chickens is retarded by hypophysec-
tomy or when endogenous GH is low, growth can be
stimulated by posthatch administration of mammalian
GH (King and Scanes, 1986). Additionally, growth rate
of intact birds was reduced by antisera against chicken
GH (Scanes, 1987). Although there are some exceptions
(Myers and Peterson, 1974; Scanes et al., 1975; Hargis et
al., 1989), mammalian GH generally has been ineffective
in stimulating growth rate, efficiency of gain, or organ
growth in the normal growing chicken during either
early or late posthatch periods (Scanes et al., 1975; Tojo et
al., 1978). Furthermore, chicken (c) GH (pituitary
derived or recombinant) does not substantially or
consistently improve growth performance variables in
the early posthatch period when administered by
injection or chronic infusion (Scanes et al., 1986; Bowen
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2Model SS-36/C, Genesis Inc., Cambridge, MA 02139.
et al., 1987; McGuinness and Cogburn, 1988; Peebles et
al., 1988; Cogburn et al., 1989).
Growth hormone is the most important hormone for
normal postnatal longitudinal bone growth. Exogenous
GH increased long (predominantly cortical bone) bone
growth in normal (Jorgensen et al., 1991; Andreassen
and Oxlund, 1996), dwarf (Wright et al., 1995; Martinez
et al., 1996), ovariectomized (Andreassen and Oxlund,
1996; Noland et al., 1996), and hypophysectomized rats
(Schiltz et al., 1992), whereas no significant effect on
cancellous bone mass was seen (Jorgensen et al., 1991).
Furthermore, these results were supported in GH-
transgenic mice with a very high concentration of GH
(Ohlsson et al., 1996) and in old female monkeys injected
with 100 mg GH/kg per d for 7 wk (Sass et al., 1997). In
the chicken, there is evidence that exogenous mam-
malian GH stimulates tibial growth of chicks during
embryonic development (Hsieh et al., 1952; Blumenthal
et al., 1954). Additionally, Hargis et al. (1989) demon-
strated that in ovo administration of ovine GH on Day 11
of embryonic development increased subsequent shank
length of 7-wk-old male broilers. Although systemic GH
administration increased circulating concentrations of
other hormones that influence bone such as insulin-like
growth factor (IGF)-I and the active vitamin D metabo-
lite (Goff et al., 1990; Klindt et al., 1996), GH stimulated
bone formation via direct interaction with bone tissue
(Baker et al., 1992; Hedner et al., 1996). Growth hormone
stimulated the proliferation of osteoblasts and the
differentiated function of these cells, such as type I
collagen synthesis, osteocalcin expression, and alkaline
phosphatase activity in primary isolated rat (Ernst and
Froesch, 1988) and chicken osteosarcoma cell culture
(Slootweg et al., 1988). Increased cortical bone growth
often has been associated with increased mechanical
strength of whole bone as a function of both the mineral
and the matrix (primarily type I collagen fibrils)
constituents (Martin and Ishida, 1989; Shah et al., 1995).
In ovo injections of either ovine or porcine GH
increased posthatch growth in male broilers (Hargis and
Pardue, 1989) and ovine GH improved feed efficiency in
male broilers (Hargis et al., 1989). However, whether
exogenous cGH in ovo has any influence on chicken
embryonic or later posthatch growth has remained
unresolved. Additionally, differences between chicken
and mammalian GH sequences (Leung et al., 1984) may
result in variations in bioactivity. Therefore, the objec-
tive of this work was to administer cGH in ovo and then
measure its effect on growth, feed efficiency, and
biomechanical properties of cortical bone development
of chickens.
MATERIALS AND METHODS
Hatching Eggs
Fertilized eggs (Hubbard ´ Hubbard) were obtained
from the West Virginia University Poultry Facilities. Eggs
(30eggspercGHtreatmentand15eggspercontrolgroup)
were injected once on one of the following Days: 1, 4, or 7
through 18 of incubation (total 630 eggs).
Injection Procedure
In ovo administration of 100 mL of either pituitary
derivedcGHorvehicle(0.03MNaHCO3,0.15MNaCl,pH
8.3) per egg was performed through the blunt end of the
eggs. Pituitary derived cGH was diluted in vehicle at 100
ng/100 mL and was stored at –20 C. Prior to injection, the
blunt end of the egg was sterilized with 70% ethanol. A
single hole was created with a dental drill bit without
penetrating the chorioallantoic membrane. Both cGH (100
ng per egg) and vehicle were injected into the albumen
with a 22-gauge needle. The hole was sealed with an
adhesive sticker. Eggs were set in a Buckeye incubator/
hatcher2 (temperature 37 ± 0.5 C, humidity 86 to 87%).
Pen Assignment and
Experimental Design
At hatching, chicks were vaccinated for Marek’s
Disease (s.c. in the neck; 0.2 cc per chick) and separated by
feather sexing. All chicks in a treatment group were
assigned to a randomly selected pen (n = 6 to 29 per pen, a
total of 28 pens).
During the first 3 wk, chicks were fed a starter ration
that contained 21.2% CP and 3,080 kcal ME/kg. Birds had
free access to feed and water. During the last 3 wk of
production, birds were fed a grower ration that contained
19.5% CP and 3,124 kcal ME/kg. Chicks were housed in a
thermostatically controlled building with a 24-h lighting
schedule.
Pen weight and mortality were recorded weekly.
Average feedconsumption and feed to gain ratios per pen
were determined weekly. At the end of the growth period
(42 d of age), treatment groups were selected for further
analysis according to feed efficiency and live weight gain.
Day 1, 11, 15 and 16 treatment groups (n = 5 to 6 birds per
treatmentgroup),aswellasassociatedcontrolgroups(n=
4 to 6 per control group) for a total of 9 to 12 chicks per
treatment daywereselectedfor furtherprocessing.Whole
body, breast muscle (both breasts and rib cage), liver,
heart, and leg (leg and thigh) data were collected.
Individual tissue or organ weights were recorded.
Texture Analysis
Pectoralis profundus was removed from each chick and
cooked to 80 C internal temperature on a Farberware
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3Model 450N, Farberware Inc., Bronx, NY 10462.
4Model 205, Beckman Instruments, San Diego, CA 92123-1898.
5Model TM, Instron Co., MA 02021.
6Daytronic, Miamisburg, OH 45342.
7Data Translation, Marlboro, MA 01752.
8Waring, New Hartford, CT 06057.
9Savant Instruments, Farmingdale, NY 11735.
10Corning Costar Corp., Cambridge, MA 02140.
11Shimadzu Scientific Inc., Columbia, MD 21046.
FIGURE 1. Cross-section of the bone model for three-point bending
tests.a,b=major and minor diametersof theellipse,t= wall thickness of
the cylindrical tube.
SmokelessIndoorGrill.3Rightorleftsideswererandomly
chosen. A Beckman Industrial Datalogger4 was used to
monitor internal cooking temperature. To determine
percentage cook yield, raw and cooked weights were
recorded. After cooked muscle was cooled to room
temperature, 1.27 cm-thick slices were cut perpendicular
to the fiber orientation of the muscle and two or three
1.27-cm-diameter cores were removed from each strip
(Kenney et al., 1996). An Instron Universal Testing
Machine,5 equipped with a Warner-Bratzler shear force
attachment (Model 1520.50)6 was used for shear force
determination. Warner-Bratzler shear force was deter-
mined by a crosshead speed of 127 mm/min. Output was
recorded via a Daytronic main frame equipped with a
LVDT conditioner (Model 9130),6 and output from the
main frame was sent to a computer with a DT 2805
acquisition board.7
Bone Biomechanical Parameters
One leg from eachchickenwasexarticulated at random
at the hip joint and kept frozen until bone measurements
were taken. Samples were thawed overnight at 2 C. The
tibias were dissected free by removing all muscle tissues,
periost, and fibula. Tibias were subjected to three-point
bending tests until failure under displacement control
(127 mm/min) using a servo Instron Universal Testing
Machine. Tests were conducted at room temperature and
specimens were kept moist during testing. Span length
was 60 mm throughout the experiment and the load was
applied at the midpoint of the shaft in antero-posterior
direction. A load cell (Model 152 A.50)6 with a maximum
capacity of 500 N was used to measure the applied load
and the maximum value of the load was recorded as
failure load (F). After failure, cortical bone thickness (t)
and cross-sectional diameter were measured on two
perpendicular axes (a and b; Figure 1) at the fracture site
using a caliper. Assuming the bone as a uniform hollow
elliptical beam, cross-sectional area (A) and moment of
inertia (Ixx) were calculated as structural parameters of
resistance (Martin, 1991; 1993) using the following
equations (Gere and Timoshenko, 1990):
A=p/4[ab – (a – 2t)(b – 2t)]
Ixx = p/64 (ab3 – (a – 2t)3)
Assuming that material properties are uniformly dis-
tributed along the beam, maximum moment (M) and
bending strength (ultimate breaking strength) (s) were
calculated as (Gere and Timoshenko, 1990)
M = FL/4
s = M (b/2)/Ixx
where L is the span length.
Ash Weight and Collagen Analysis
Following mechanical testing, bones were cut into
0.5- to 1-cm strips using a band saw and subsequently
frozen in liquid nitrogen. Frozen samples were powdered
in a prechilled stainless steel Waring blender.8 Approxi-
mately 4 to 6 mg of each duplicate bone powder sample
was transferred to weighed dry crucibles. Dry weight was
determined following heating to constant weight at 110 C
for 2 h. Ash weight was determined following overnight
heating at 600 C in a muffled furnace and expressed as
percentage of dry bone weight. Hydroxyproline concen-
tration was measured by the method of Monnier et al.,
(1986) as an indicator of collagen content. Briefly, 40 mg of
duplicate powdered bone sample was delipidated over-
night in a chloroform:methanol (2:1) solution. Samples
were then rehydrated in 50% methanol and hydrolyzed in
6 N HCl at 110 C for 18 h. Prior to capping for heating, N2
was used to flush all tubes. Following hydrolysis, the
samples were evaporated in a Speed Vac centrifuge
vacuum drier.9 Subsequently, samples were reconstituted
in 250 mL distilled H2O and filtered using a Costarâ Spin-
Xâ centrifuge tube filter.10 Samples were analyzed for
hydroxyproline concentrations at 564 nm wavelength
using a Shimadzu spectrophotometer (Model UV-1201).11
Statistical Analysis
Analysis of variance was performed by the GLM
procedures of SASâ (SAS Institute, 1989) as a three-factor
factorial arrangement of treatments in a completely
random design. A previous experiment indicated that the
variance among chicks within a pen was a valid estimate
ofexperimentalerror.TheLeastSignificantDifferencetest
was used to compare the means. The CATMOD test was
used to compare hatchability. Statements of significance
were based on P < 0.05 unless otherwise noted.
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TABLE 1. Effects of in ovo chicken growth hormone (cGH)
administration on broiler hatchability (n = 30 for each
treatment group, n = 15 for each control group)
1Chicken growth hormone.
2Vehicle-injected control groups.
*P < 0.05 compared to other injection days.
Injection
day Treatment1 Control2
(%)
16 8 ± 9.3* 50 ± 14.4*
4 69.9 ± 9.5* 66 ± 8.1*
7 83.3 ± 5.7 90.2 ± 8.9
8 92.6 ± 5 84.6 ± 10
9 88.9 ± 6 85.7 ± 9.3
10 86.1 ± 6.5 84.6 ± 10
11 85.7 ± 6.6 92.3 ± 7.4
12 88 ± 7.2 96 ± 2.1
13 86.7 ± 6.3 86.7 ± 8.8
14 93.1 ± 4.7 92.8 ± 6.9
15 98 ± 2.6 92.8 ± 6.9
16 96.5 ± 3.4 86.7 ± 8.8
17 86.7 ± 6.3 93 ± 2.6
18 89.3 ± 5.8 93.3 ± 6.4
FIGURE 2. Effects of in ovo chicken growth hormone (cGH)
administration on live (panel A) and liver weights (panel B) of
42-d-old broilers. The bars represent the means of males (n = 4 to 6) and
females (n = 4 to 6) in each treatment and control (Cont.) group. Means
with asterisks are significantly different from their respective control
groups (**P < 0.01, *P < 0.05). Vertical lines are SEM.
RESULTS
There were no significant differences in hatchability
between control and cGH treatment groups on any
injection day (Table 1). However, injection of either cGH
or vehicle on Day 1 or 4 of incubation compared to other
injection days reduced hatchability (P < 0.05; Table 1).
Measurements of Growth Performance
In ovo administration of cGH on Day 15 or 16 of
incubation increased body weight of female broilers (P <
0.01; Figure 2), whereas body weights of male broilers
were increased by Day 1 treatment (P < 0.04; Figure 2).
Pooled mean cumulative feed conversion ratio of all
treatment groups at the end of the treatment period was
improved compared to their respective control groups
(forcGHtreatedgroups:1.81±0.02,for control groups:1.9
± 0.03; P < 0.05). As there were no significant differences
either among the treatment groups or among the control
groups in terms of feed conversion ratios, values were
represented as pooled means.
Breast weights of female broilers from treatment
groups Day 15 or 16 were increased (P < 0.01, P < 0.05
respectively;Table2).Ontheotherhand,breastweightsof
male broilers were not altered significantly by in ovo
administration of cGH on any given injection day (Table
2). Liver weights of female broilers from treatment Day 15
were increased (P < 0.01; Figure 2). In contrast, in ovo
administration of cGH on Day 11 of incubation increased
liver weights of male broilers (P < 0.03; Figure 2). There
were no significant differences between control and
treatment groups on any single injection day in terms of
heart and leg weights other than sex effects (Table 2).
Warner-Bratzler shear force ratios on P. profundus muscle
between treatment and control groups were not different
on any given injection day.
Bone Analysis
In ovo administration of cGH on Day 11 or Day 16
increased hydroxyproline concentration and cross-
sectional area of female broiler tibias (P < 0.05, Table 3).
This increase was associated with a reduction in the
ultimate breaking strength (stress) of female broiler tibias
from the same groups (P < 0.05; Table 3); however, there
was no significant difference in male broiler tibias for
these measurements (Table 3). In ovo administration of
cGH did not alter percentage ash, tibia density, weight,
length, cortical bone thickness and breaking force of tibias
on any given injection day (Table 3).
DISCUSSION
A single in ovo administration of cGH increased body
weight and tissue development of 42-d-old broilers,
although the magnitude of the responses were different
between male and female broilers. Feed conversion
ratios of all in ovo cGH injected mixed-sex broilers were
improved significantly compared to their respective
control groups. Although the specific mechanism of GH
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TABLE 2. Effects of in ovo chicken growth hormone (cGH) administration on heart, leg, and
breast weights of 42-d-old broilers (x ± SEM, n = 5 to 6 for each treatment and control group)
**P < 0.01, *P < 0.05, compared to their respective control groups within the same sex.
Heart weight Leg weight Breast weight
Injection day Male Female Male Female Male Female
(g)
Day 1
cGH 11.2 ± 1.2 9.1 ± 1.2 143.9 ± 18.9 130.3 ± 18.9 502 ± 34.4 453 ± 34.4
Control 10.8 ± 1.4 8.1 ± 1 136.7 ± 26.7 114 ± 15.4 433 ± 48.7 421.3 ± 28.1
Day 11
cGH 10.1 ± 1.2 9.2 ± 0.8 166.2 ± 18.9 122.1 ± 13.3 439.3 ± 34.4 403.7 ± 24.3
Control 11.3 ± 0.8 8.9 ± 1.2 145.1 ± 13.3 133.1 ± 18.9 470.8 ± 24.4 373.6 ± 34.4
Day 15
cGH 11.4 ± 1 8.7 ± 1 162.6 ± 15.4 128.2 ± 15.4 492.8 ± 28.1 441.3 ± 28.1**
Control 13 ± 1 9.5 ± 1 142.3 ± 15.4 107.5 ± 15.4 468.8 ± 28.1 370.3 ± 28.1
Day 16
cGH 10.3 ± 1 7.7 ± 1 152.4 ± 15.4 113.5 ± 15.4 466 ± 28.1 388.9 ± 28.1*
Control 11.6 ± 1 6.8 ± 1 117.6 ± 15.4 100.2 ± 15.4 451.8 ± 28.1 332.6 ± 18.6
TABLE 3. Effects of in ovo chicken growth hormone (cGH) on biomechanical properties of 42-d-old broiler tibias
(n = 5 to 6 for each treatment and control group)1
1M = male; F = female; OH-proline = hydroxyproline; *P < 0.05 compared to respective control group within same sex.
Tibia Cortical Breaking Cross-section
Injection
day
Ash OH-proline length Density Weight thickness force Stress area
MF MF MF MF MF MF MF MF M F
(%) (mg/mg) (mm) (g/cm3) (g) (mm) (kg) (Mpa) (mm2)
Day 1
cGH 62 62 9 7 105 106 1.3 1.3 18 17 1.4 1.2 40 35 231 166 22 19
Control 59 59 9 10 106 106 1.2 1.2 18 15 1.5 1.2 36 29 189 203 23 17
Day 11
cGH 62 62 8 11* 105 103 1.2 1.3 21 18 1.5 1.4 50 42 172 178* 29 27*
Control 64 59 8 7 107 103 1.2 1.2 20 16 1.4 1.2 37 49 146 258 26 19
Day 15
cGH 61 62 11 9 107 103 1.2 1.3 20 16 1.2 1.4 43 37 157 169 23 24
Control 64 63 10 10 102 101 1.2 1.2 20 15 1.7 1.4 40 34 152 176 29 23
Day 16
cGH 62 65 8 10* 106 102 1.1 1.2 21 15 1.6 1.4 37 39 140 145* 29 25*
Control 62 65 9 7 102 97 1.2 1.3 22 12 1.8 1.3 44 30 136 296 33 16
action resulting in these various responses in male and
female broilers is unknown, partial explanations for the
observed findings could be due to sexual-dimorphism,
altered thyroid function, and IGF-I and insulin-like
growth factor binding proteins (IGFBP) function and
expression.
Thyroid hormone metabolism has been linked to the
regulation of GH action and the growth process of
chickens (Singh et al., 1968; Scanes, 1987). The thyroid is
functional early in embryonic development and becomes
pituitary dependent at Day 10 to 12 of embryogenesis
(Thommes and Jameson, 1980). Moreover, GH regulates
thyroxine secretion in growing chickens and regulates
the circulating concentration of triiodothyronine in adult
chickens and embryos by inducing 5¢-monodeiodinase
activity inside the liver cell (Kuhn et al., 1986; Darras et
al., 1990). Thus, it is possible that exogenous GH in this
study had the effect of modifying thyroid hormone
secretion.
Insulin-like growth factor-I is required for normal
growth in chickens (Proudman et al., 1994). In a previous
study, we demonstrated that in ovo administration of
recombinant human IGF-I (100 ng per embryo) altered
body weights and tissue development of 42-d-old
broilers (Kocamis et al., 1998). Unlike mammalian cell
culture, avian growth plate chondrocytes from birds of
different ages do not respond to the addition of GH to
the culture medium in terms of IGF-I concentrations
(Rosselot et al., 1994). Additionally, the effect of GH on
IGF-I is not consistent although exogenous studies have
demonstrated GH to either increase (Leung et al., 1986;
Vasilatos-Younken et al., 1990) or be without effect on
IGF-I in the circulation (Cogburn et al., 1989; Rosselot et
al., 1995) in avian species. During chicken embryonic
development, IGF-I gene expression is GH-independent
(Kikuchi et al., 1991; Tanaka et al., 1996). However, IGF-I
gene expression in bone tissue is not GH-dependent
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either before or after hatching (Tanaka et al., 1996). For
this reason, the influence of in ovo administration of IGF-
I during embryonic development on postnatal long bone
growth is under investigation in our laboratory.
There are six distinct classes of IGFBP found in
extracellular fluid and serum of mammals, termed
IGFBP-1 through IGFBP-6 (Hill, 1996). The bioactivity of
IGF, particularly in bone tissue, is modulated by these
IGFBP. For example, mRNA for IGFBP-5, which is a
stimulatory IGFBP for osteoblast proliferation (Bautista
et al., 1991), was increased twofold after GH treatment of
primary rat osteoblasts (McCarthy et al., 1994). However,
only IGFBP-2 (Schoen et al., 1995) and IGFBP-5 (Allander
et al., 1995) have been isolated in chicken serum. It is not
known whether these IGFBP in chicken are similar in
function to those in mammals. It has been suggested that
GH may regulate circulating concentrations of chicken
IGFBP (Scanes, 1997). Therefore, whether increased
concentrations of circulating GH during embryonic
development of the chicken has any effect on specific
type of IGFBP could be of interest.
There is a sexual dimorphism between growth and
GH concentrations in chickens. Some evidence impli-
cates testosterone in the physiological control of GH
secretion (Harvey et al., 1979). Also, during the early (0
to 3 wk) posthatch period, male broilers grow faster,
have larger body size, and display higher circulating GH
concentrations than females (Leung et al., 1987;
Vasilatos-Younken et al., 1990). However, there is no sex
difference in hepatic binding of GH for broiler chickens
at Day 1 of age or during the late posthatch period
(Leung et al., 1987). These studies could, to some extent,
explain the varying response of in ovo injection of GH
during different days of incubation between the male
and female.
In ovo administration of cGH on Day 11 or 16 of
incubation resulted in a greater response in the bi-
omechanical properties of the tibias of female broilers.
For example, cross-sectional areas and hydroxyproline
concentrations of these bones were significantly in-
creased. However, their ultimate breaking strength
ratios were reduced, indicating that increased bone mass
was not associated with strength. There was no
significant effect on percentage ash ratio, tibia length,
weight, density, cortical bone thickness, or breaking
force ratios found on any given day of injection. These
results could be due, in part, to the changes in moisture
content, bone cell number, collagen cross-linking, cir-
culating levels of other hormones such as the active
vitamin D metabolite, and bone turnover.
Chorioallantoic injections of GH (5 mg per embryo) on
Day 13 of incubation and continued every other day for
5 d increased hatch weights and tibial growth of
chickens (Hsieh et al., 1952). In that study, female chicks
were more sensitive to GH than were their male
counterparts. In contrast, Hargis et al. (1989) showed
that in ovo administration of ovine GH (250 mg per
embryo) on Day 11 of incubation resulted in a greater
response in male broilers. In our study, we did not find
a significant effect of in ovo cGH on this day for any
measures of growth other than increased weight of the
male liver. Additionally, there was no significant
difference between treated and control groups in terms
of hatch weight of broilers. As chicken GH (100 ng per
embryo) was administered to embryos from Hubbard ´
Hubbard broiler strains in this study, these variations in
response could be due to the differences in the type of
GH, dosage, and genetic line of the broilers.
Warner-Bratzler shear force ratios between in ovo-
injected treatment and control groups were not different
on any given injection day in this study. Likewise, we
reported earlier that in ovo administration of recom-
binant human IGF-I did not alter shear force ratios in
either male or female broilers (Kocamis et al., 1998).
Therefore, in ovo administration of cGH or recombinant
human IGF-I does not detract from product quality.
In conclusion, in ovo administration of cGH on Day 1
(males) and Day 15 or 16 (females) of embryonic
development increased body weights and altered tissue
development of 42-d-old broilers. Increased body
weights of female broilers from treatment groups Day 15
or Day 16 were associated with increased breast
weights. Moreover, feed conversion ratios of all treat-
ment groups were increased significantly compared to
their respective control groups. In ovo administration of
cGH on Day 11 or 16 of incubation increased hydrox-
yproline concentration and cross-sectional area of the
tibia from female broilers. There was no significant
difference between treatment and control groups in
terms of Warner-Bratzler shear force on any given
injection day. Therefore, in ovo administration of cGH on
specific days may provide a means of increasing broiler
growth rate and efficiency without altering quality of
the products.
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